Clinical Trials Browser

Interventional × Mesothelioma, Malignant × spartalizumab × Clear all

NCT03393858 2024-02-07

Combination of Immunotherapy and Hyperthermia in Advanced Malignant Mesothelioma

Phase 1/2 Terminated

Other solid neoplasmThoracic

Mesothelioma, Malignant, Neoplasms